Skip to main content

Danaher Value Stock - Dividend - Research Selection

Danaher

ISIN: US2358511028 , WKN: 866197

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company\'s Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians\' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 Reasons to Sell DHR and 1 Stock to Buy Instead

2025-09-30
Over the last six months, Danaher’s shares have sunk to $186.35, producing a disappointing 9.1% loss - a stark contrast to the S&P 500’s 18.6% gain. This may have investors wondering how to approach the situation.

Here's Why Envista (NVST) is a Strong Value Stock

2025-09-29
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Rosen Law Firm Initiates Investigating Potential Breaches of Fiduciary Duty by Danaher Corporation (DHR)

2025-09-27
With significant upside potential, Danaher Corporation (NYSE:DHR) secures a spot on our list of the 13 Best Diversified Stocks to Buy According to Hedge Funds. On September 20, 2025, Rosen Law Firm announced that it is investigating potential breaches of fiduciary duty by Danaher Corporation (NYSE:DHR)’s directors and officers. Accordingly, the law firm encouraged shareholders […]

Will Danaher's (DHR) New Gene Editing Tool Redefine Its Position in Advanced Life Sciences?

2025-09-27
Integrated DNA Technologies (IDT), a Danaher company, recently launched the Alt-R HDR Enhancer Protein, designed to improve homology-directed repair efficiency in gene editing and manufactured by Aldevron, which also operates under Danaher. This breakthrough expands Danaher's capabilities in the competitive cell and gene therapy market by providing a solution that increases gene editing efficiency without sacrificing cell viability or genomic integrity. We’ll examine how this new gene...

Danaher Corp. stock outperforms competitors on strong trading day

2025-09-26
Danaher Corp. stock outperforms competitors on strong trading day

Danaher Corp. stock underperforms Thursday when compared to competitors

2025-09-25
Danaher Corp. stock underperforms Thursday when compared to competitors

Integrated DNA Technologies Launches New Enhancer Protein to Accelerate CRISPR-Based Therapies from Translational Research to Clinical Breakthrough

2025-09-25
CORALVILLE, Iowa, September 25, 2025--New enhancer protein expands IDT's market-leading portfolio of HDR reagents, empowering cell and gene therapy developers to accelerate discoveries

Danaher Corp. stock underperforms Wednesday when compared to competitors

2025-09-24
Danaher Corp. stock underperforms Wednesday when compared to competitors

1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds

2025-09-24
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Danaher Schedules Third Quarter 2025 Earnings Conference Call

2025-09-23
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2025 on Tuesday, October 21, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations.